Skip to main content
Canadian Family Physician logoLink to Canadian Family Physician
. 1989 Oct;35:2115–2118.

Control of Influenza: When Do I Use Amantadine?

Ann McCullough
PMCID: PMC2280922  PMID: 21249092

Abstract

Influenza causes significant morbidity and mortality in Canada yearly despite the availability of vaccine and the antiviral drug amantadine (Symmetrel®). Vaccine is prepared annually against specific subtypes of influenza A and B that are anticipated to predominate during the winter months. The vaccine should be given in early autumn to patients considered at high risk for the sequelae of influenza. Amantadine, which was first marketed for the treatment of influenza in the early 1960s, is effective in the prevention and early treatment of illness caused by influenza A and is ineffective against influenza B. The drug is available in oral form and should be used as an adjunct to immunization or as an alternative in those for whom immunization is contraindicated or ineffective.

Keywords: amantadine, infectious diseases, influenza control, pharmaceutic therapy, vaccination

Full text

PDF
2115

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Dolin R., Reichman R. C., Madore H. P., Maynard R., Linton P. N., Webber-Jones J. A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection. N Engl J Med. 1982 Sep 2;307(10):580–584. doi: 10.1056/NEJM198209023071002. [DOI] [PubMed] [Google Scholar]
  2. Douglas R. G., Jr Prevention, management, and control of influenza: a mandate for the 1980s. Am J Med. 1987 Jun 19;82(6A):1–3. doi: 10.1016/0002-9343(87)90553-5. [DOI] [PubMed] [Google Scholar]
  3. Farnebo L. O., Fuxe K., Goldstein M., Hamberger B., Ungerstedt U. Dopamine and noradrenaline releasing action of amantadine in the central and peripheral nervous system: a possible mode of action in Parkinson's disease. Eur J Pharmacol. 1971 Sep;16(1):27–38. doi: 10.1016/0014-2999(71)90053-7. [DOI] [PubMed] [Google Scholar]
  4. Ing T. S., Daugirdas J. T., Soung L. S., Klawans H. L., Mahurkar S. D., Hayashi J. A., Geis W. P., Hano J. E. Toxic effects of amantadine in patients with renal failure. Can Med Assoc J. 1979 Mar 17;120(6):695–698. [PMC free article] [PubMed] [Google Scholar]
  5. Tominack R. L., Hayden F. G. Rimantadine hydrochloride and amantadine hydrochloride use in influenza A virus infections. Infect Dis Clin North Am. 1987 Jun;1(2):459–478. [PubMed] [Google Scholar]
  6. Van Voris L. P., Betts R. F., Hayden F. G., Christmas W. A., Douglas R. G., Jr Successful treatment of naturally occurring influenza A/USSR/77 H1N1. JAMA. 1981 Mar 20;245(11):1128–1131. doi: 10.1001/jama.245.11.1128. [DOI] [PubMed] [Google Scholar]
  7. Wilson T. W., Rajput A. H. Amantadine-dyazide interaction. Can Med Assoc J. 1983 Nov 1;129(9):974–975. [PMC free article] [PubMed] [Google Scholar]

Articles from Canadian Family Physician are provided here courtesy of College of Family Physicians of Canada

RESOURCES